Cargando…
Single-cell RNA sequencing reveals that targeting HSP90 suppresses PDAC progression by restraining mitochondrial bioenergetics
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, which lacks effective treatment strategies. There is an urgent need for the development of new strategies for PDAC therapy. The genetic and phenotypic heterogeneity of PDAC cancer cell populations poses further challenges in th...
Autores principales: | Hu, Li-Peng, Zhou, Kai-Xia, Huo, Yan-Miao, Liu, De-Jun, Li, Qing, Yang, Min-Wei, Huang, Pei-Qi, Xu, Chun-Jie, Tian, Guang-Ang, Yao, Lin-Li, Zhang, Xue-Li, Wang, Ya-Hui, Li, Jun, Zhang, Zhi-Gang, Jiang, Shu-Heng, Xing, Xin, Wang, Xu, Qin, Wei-Ting, Yang, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930118/ https://www.ncbi.nlm.nih.gov/pubmed/33658487 http://dx.doi.org/10.1038/s41389-021-00311-4 |
Ejemplares similares
-
Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer Cells
por: Qin, Dong-Jun, et al.
Publicado: (2015) -
Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance
por: He, Yan, et al.
Publicado: (2023) -
Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation
por: Xu, Yonghua, et al.
Publicado: (2023) -
Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment
por: Donahue, Kristine, et al.
Publicado: (2022) -
The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)